Summary by Futu AI
On June 26, 2024, Fosun Pharma in Shanghai held the 2023 Shareholders Meeting, the 2024 First A-Share Class Shareholders Meeting, and the H-Share Class Shareholders Meeting. During the meeting, several proposals were passed, but the proposal to amend the Articles of Association and its attachments did not receive the necessary two-thirds of the shares passed at the H-Share Class Shareholders Meeting and was therefore rejected. The rejection of the proposal will not affect the daily operation of the group. The convocation, holding and voting methods of the meeting comply with relevant laws and regulations and the provisions of the Articles of Association, and have been witnessed by Guohao Law Firm (Shanghai). The Board of Directors reiterated that the purpose of amending the Articles of Association is to align with the latest regulations of laws and regulations and the regulatory requirements of the listing place.